Published in Methods Enzymol on January 01, 1990
Blockade of endogenous leukotrienes exacerbates pulmonary histoplasmosis. Infect Immun (2004) 1.19
Production of leukotrienes in a model of focal cerebral ischaemia in the rat. Br J Pharmacol (2001) 1.03
Effects of compounds extracted from Santolina oblongifolia on TXB(2) release in human platelets. Inflammopharmacology (1998) 0.86
Inhibition by troglitazone of the antigen-induced production of leukotrienes in immunoglobulin E-sensitized RBL-2H3 cells. Br J Pharmacol (2000) 0.85
Toward antibody-catalyzed hydrolysis of organophosphorus poisons. Proc Natl Acad Sci U S A (2000) 0.77
Activation of human aortic smooth-muscle cells is inhibited by PPARalpha but not by PPARgamma activators. Nature (1998) 3.48
Radioimmunoassay of prostaglandins Falpha, E1 and E2 in human plasma. Eur J Clin Invest (1975) 2.80
Enzyme immunoassays of eicosanoids using acetylcholine esterase as label: an alternative to radioimmunoassay. Anal Chem (1985) 2.22
Increased expression of inducible nitric oxide synthase and cyclo-oxygenase-2 in the airway epithelium of asthmatic subjects and regulation by corticosteroid treatment. Thorax (2001) 1.95
Elevated levels of 8-iso-prostaglandin F2alpha in pericardial fluid of patients with heart failure: a potential role for in vivo oxidant stress in ventricular dilatation and progression to heart failure. Circulation (1998) 1.90
Biochemical and pharmacological characterization of the cyclooxygenase activity of human blood prostaglandin endoperoxide synthases. J Pharmacol Exp Ther (1994) 1.79
Demonstration of an inducible cyclooxygenase in human endothelial cells using antibodies raised against the carboxyl-terminal region of the cyclooxygenase-2. J Biol Chem (1993) 1.65
Reversible inhibitory effects and absence of toxicity of the tetrapeptide acetyl-N-Ser-Asp-Lys-Pro (AcSDKP) in human long-term bone marrow culture. Exp Hematol (1992) 1.49
Clinical relevance of preformed HLA donor-specific antibodies in kidney transplantation. Am J Transplant (2007) 1.49
Humanized anti-CD20 monoclonal antibody (Rituximab) in post transplant B-lymphoproliferative disorder: a retrospective analysis on 32 patients. Ann Oncol (2000) 1.43
Competitive enzyme immunoassay with monoclonal antibody for homovanillic acid measurement in human urine samples. Clin Chem (1997) 1.39
Immunological characterization of urinary 8-epi-prostaglandin F2 alpha excretion in man. J Pharmacol Exp Ther (1995) 1.38
Localization of distinct F2-isoprostanes in human atherosclerotic lesions. J Clin Invest (1997) 1.38
Cyclooxygenase-2 is widely expressed in atherosclerotic lesions affecting native and transplanted human coronary arteries and colocalizes with inducible nitric oxide synthase and nitrotyrosine particularly in macrophages. Arterioscler Thromb Vasc Biol (1999) 1.35
Segmental synthesis and actions of prostaglandins along the nephron. Am J Physiol (1987) 1.34
Role of the serotonin transporter gene in the behavioral expression of autism. Mol Psychiatry (2001) 1.30
Determinants of poor graft outcome in patients with antibody-mediated acute rejection. Am J Transplant (2007) 1.24
Interaction of vasculotropin/vascular endothelial cell growth factor with human umbilical vein endothelial cells: binding, internalization, degradation, and biological effects. J Cell Physiol (1991) 1.23
Analytical methods for thromboxane B2 measurement and validation of radioimmunoassay by gas liquid chromatography-mass spectrometry. Prostaglandins (1978) 1.21
Stimulation of leukotriene biosynthesis in human blood leukocytes by platelet-derived 12-hydroperoxy-icosatetraenoic acid. Proc Natl Acad Sci U S A (1982) 1.20
PGE2, PGF2 alpha, 6-keto-PGF1 alpha, and TxB2 synthesis along the rabbit nephron. Am J Physiol (1987) 1.17
Enzyme immunoassays of eicosanoids using acetylcholinesterase. Methods Enzymol (1990) 1.15
Production of monoclonal antibodies against interleukin-1 alpha and -1 beta. Development of two enzyme immunometric assays (EIA) using acetylcholinesterase and their application to biological media. J Immunol Methods (1989) 1.15
Early expression of cyclo-oxygenase-2 during sporadic colorectal carcinogenesis. J Pathol (1999) 1.12
The antagonism induced by ruthenium red of the actions of capsaicin on the peripheral terminals of sensory neurons: further studies. Eur J Pharmacol (1988) 1.12
Enzyme immunoassays of adenosine cyclic 3',5'-monophosphate and guanosine cyclic 3',5'-monophosphate using acetylcholinesterase. Anal Chem (1989) 1.12
Tyrosine phosphorylation of cortactin associated with Syk accompanies thromboxane analogue-induced platelet shape change. J Biol Chem (1999) 1.10
Role of NF-kappaB in the antiproliferative effect of endothelin-1 and tumor necrosis factor-alpha in human hepatic stellate cells. Involvement of cyclooxygenase-2. J Biol Chem (1998) 1.09
Induction versus noninduction in renal transplant recipients with tacrolimus-based immunosuppression. Transplantation (2001) 1.08
Phosphorylation of the thromboxane receptor alpha, the predominant isoform expressed in human platelets. J Biol Chem (1999) 1.07
Expression and activity of prostaglandin endoperoxide synthase-2 in agonist-activated human neutrophils. FASEB J (1998) 1.07
Basal expression of cyclooxygenase-2 and nuclear factor-interleukin 6 are dominant and coordinately regulated by interleukin 1 in the pancreatic islet. Proc Natl Acad Sci U S A (1998) 1.06
The relationship of hydroxyeicosatetraenoic acids and F2-isoprostanes to plaque instability in human carotid atherosclerosis. J Clin Invest (1999) 1.05
A comparison of bradykinin- and capsaicin-induced myocardial and coronary effects in isolated perfused heart of guinea-pig: involvement of substance P and calcitonin gene-related peptide release. Br J Pharmacol (1989) 1.04
Leukotriene E4 elimination and metabolism in normal human subjects. J Biol Chem (1990) 1.04
Analysis of 6-keto PGF1 alpha, 5-HETE, and LTC4 in rat lung: comparison of GM/MS, RIA, and EIA. Prostaglandins (1986) 1.03
Gray platelet syndrome: alpha-granule deficiency. Its influence on platelet function. J Lab Clin Med (1981) 1.03
Differential measurement of constitutive (COX-1) and inducible (COX-2) cyclooxygenase expression in human umbilical vein endothelial cells using specific immunometric enzyme immunoassays. Biochim Biophys Acta (1995) 1.02
Regulation of cyclooxygenase-2 expression in aortic smooth muscle cells. Arterioscler Thromb (1994) 1.02
Cyclooxygenase-1 and -2 of endothelial cells utilize exogenous or endogenous arachidonic acid for transcellular production of thromboxane. J Biol Chem (1996) 1.01
Radioimmunoassay of methionine- and leucine-enkephalins in regions of rat brain and comparison with endorphins estimated by a radioreceptor assay. J Neurochem (1978) 1.01
Human herpes virus-8 and other risk factors for Kaposi's sarcoma in kidney transplant recipients. Groupe Cooperatif de Transplantation d' Ile de France (GCIF). Transplantation (1999) 1.00
Regulation of the expression of cyclooxygenase-2 by nitric oxide in rat peritoneal macrophages. J Immunol (1997) 1.00
Development, validation and application of an enzyme immunoassay (EIA) of atriopeptin. Biochem Biophys Res Commun (1987) 1.00
Nature and bioactivity of gonadotropin-releasing hormone (GnRH) secreted during the GnRH surge. Endocrinology (1995) 1.00
Effect of lupus anticoagulant on antithrombogenic properties of endothelial cells--inhibition of thrombomodulin-dependent protein C activation. Thromb Haemost (1988) 0.99
Radioimmunoassay for tubulin detection. FEBS Lett (1977) 0.99
Reversible membrane association of neutrophil 5-lipoxygenase is accompanied by retention of activity and a change in substrate specificity. J Biol Chem (1992) 0.99
Impaired nitric oxide- and prostaglandin-mediated responses to flow in resistance arteries of hypertensive rats. Hypertension (1997) 0.98
Cyclooxygenases in human and mouse skin and cultured human keratinocytes: association of COX-2 expression with human keratinocyte differentiation. Exp Cell Res (1996) 0.97
Cyclooxygenase-2 and synthesis of PGE2 in human bronchial smooth-muscle cells. Am J Respir Crit Care Med (1997) 0.96
New concepts in the modulation of leukotriene synthesis. Biochem Pharmacol (1983) 0.96
Aspirin-sensitive asthma: abnormal platelet response to drugs inducing asthmatic attacks. Diagnostic and physiopathological implications. Int Arch Allergy Appl Immunol (1985) 0.96
Clinical relevance of preformed HLA donor-specific antibodies in kidney transplantation. Contrib Nephrol (2008) 0.96
Absence of plasma prostacyclin stimulating activity deficiency in hemolytic uremic syndrome. J Pediatr (1987) 0.95
Effects of prostacyclin on the pulmonary vascular tone and cardiac contractility of patients with pulmonary hypertension secondary to end-stage heart failure. Am J Cardiol (1998) 0.94
Rapid, agonist-dependent phosphorylation in vivo of human thromboxane receptor isoforms. Minimal involvement of protein kinase C. J Biol Chem (1997) 0.93
Substance-P-like levels in inflammatory exudates. Inflammation (1988) 0.93
How many times can parvovirus B19-related anemia recur in solid organ transplant recipients? Transpl Infect Dis (2012) 0.93
Evidence that epithelium-derived relaxing factor released by bradykinin in the guinea pig trachea is nitric oxide. Am J Respir Crit Care Med (1996) 0.92
Neutrophil-platelet adhesion: relative roles of platelet P-selectin and neutrophil beta2 (DC18) integrins. Am J Respir Cell Mol Biol (1998) 0.92
Aseptic loosening of total hip replacement. Macrophage expression of inducible nitric oxide synthase and cyclo-oxygenase-2, together with peroxynitrite formation, as a possible mechanism for early prosthesis failure. J Bone Joint Surg Br (1997) 0.92
Cytokine-induced prostaglandin E2 synthesis and cyclooxygenase-2 activity are regulated both by a nitric oxide-dependent and -independent mechanism in rat osteoblasts in vitro. J Biol Chem (1999) 0.92
Pathology and human immunodeficiency virus expression in placentas of seropositive women. J Infect Dis (1991) 0.91
A solid-phase immobilized epitope immunoassay (SPIE-IA) permitting very sensitive and specific measurement of angiotensin II in plasma. J Immunol Methods (1999) 0.91
Isolation of dermenkephalin from amphibian skin, a high-affinity delta-selective opioid heptapeptide containing a D-amino acid residue. FEBS Lett (1989) 0.91
125I derivatives of prostaglandins. A novel approach in prostaglandin analysis by radioimmunoassay. Biochim Biophys Acta (1976) 0.91
In vivo platelet activation in beta-thalassemia major reflected by increased platelet-thromboxane urinary metabolites. Blood (1991) 0.90
Tritium labelling of 8-lysine vasopressin and its purification by affinity chromatography on sepharose bound neurophysins. FEBS Lett (1972) 0.90
Radioimmunoassay of arthropod moulting hormone:beta-ecdysone antibodies production and 125 I-iodinated tracer preparation. FEBS Lett (1976) 0.89
Radioimmunoassay for a vitamin-D dependent calcium-binding protein in rat duodenal mucosa. Biochem Biophys Res Commun (1977) 0.89
Induction of prostaglandin endoperoxide synthase-2 in human monocytes associated with cyclo-oxygenase-dependent F2-isoprostane formation. Br J Pharmacol (1996) 0.88
Platelet-activating factor and leukotriene biosynthesis in whole blood. A model for the study of transcellular arachidonate metabolism. J Immunol (1989) 0.88
Involvement of tyrosine kinases in the induction of cyclo-oxygenase-2 in human endothelial cells. Biochem J (1995) 0.88
Human interleukin-1 induces a rapid relaxation of the rabbit isolated mesenteric artery. Br J Pharmacol (1991) 0.87
Elevated levels of tachykinin-like immunoreactivity in joint fluids from patients with rheumatic inflammatory diseases. N Engl J Med (1986) 0.87
Induction of cyclo-oxygenase-2 in human endothelial cells by SIN-1 in the absence of prostaglandin production. Br J Pharmacol (2001) 0.87
Triphosphoinositide breakdown and dense body release as the earliest events in thrombin-induced activation of human platelets. Biochem Biophys Res Commun (1983) 0.87
Prostaglandin E2 downregulates inducible nitric oxide synthase expression in microglia by increasing cAMP levels. Adv Exp Med Biol (1997) 0.87
A new alternative transcript encodes a 60 kDa truncated form of integrin beta 3. Biochem J (1994) 0.87
Regulation of sarco-endoplasmic reticulum Ca(2+)-ATPases during platelet-derived growth factor-induced smooth muscle cell proliferation. J Biol Chem (1992) 0.86
Heme oxygenase-1 induction by nitric oxide in RAW 264.7 macrophages is upregulated by a cyclo-oxygenase-2 inhibitor. Biochim Biophys Acta (2001) 0.86
Radioimmunoassay of 11-dehydrothromboxane B2 in human plasma and urine. Biochim Biophys Acta (1987) 0.86
[Study of the relationships between self-injurious behavior and pain reactivity in infantile autism]. Encephale (1999) 0.86
Imbalance of thromboxane/prostacyclin biosynthesis in patients with lupus anticoagulant. Blood (1991) 0.85
A sensitive and specific enzyme immunoassay for cyclomaltoheptaose and some derivatives. Carbohydr Res (1994) 0.85
Immunological studies of human constitutive cyclooxygenase (COX-1) using enzyme immunometric assay. Biochim Biophys Acta (1995) 0.85
Increased in vivo production of thromboxane in patients with sickle cell disease is accompanied by an impairment of platelet functions to the thromboxane A2 agonist U46619. Arterioscler Thromb (1993) 0.85